Industry Research Reports

Home > Reports > Consumer Goods > RNA Analysis & Transcriptomic - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

RNA Analysis & Transcriptomic - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Consumer Goods

Published Date: 2026-07-14

Pages: 121 Pages

Report ld: 6910355

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for RNA Analysis & Transcriptomic was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.

The North American market for RNA Analysis & Transcriptomic was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.

The Asia-Pacific market for RNA Analysis & Transcriptomic was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.

The European market for RNA Analysis & Transcriptomic was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.

The global key companies in the RNA Analysis & Transcriptomic market include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Merck KGaA, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Danaher Corporation, Fluidigm Corporation, Eurofins Scientific, Sequentia Biotech SL, Acobiom, etc. In 2025, the five largest players accounted for approximately % of revenue.

This report provides a comprehensive view of the global market for RNA Analysis & Transcriptomic, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The RNA Analysis & Transcriptomic market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding RNA Analysis & Transcriptomic.

MARKET SEGMENTATION

By Company

Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc.
Merck KGaA
Agilent Technologies, Inc.
F. Hoffmann-La Roche Ltd.
Danaher Corporation
Fluidigm Corporation
Eurofins Scientific
Sequentia Biotech SL
Acobiom
GenXPro GmbH
CD Genomics
Promega Corporation
Cenix BioScience GmbH
Takara Holdings, Inc.
bioMérieux SA
LC Sciences LLC

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Microarrays
Sequencing
Polymerase Chain Reaction
RNA Interference

Segment by Application

Clinical Diagnostics
Drug Discovery
Toxicogenomics
Comparative Transcriptomics

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.

Chapter 2: Provides a detailed analysis of the RNA Analysis & Transcriptomic companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents RNA Analysis & Transcriptomic revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents RNA Analysis & Transcriptomic revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.

Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 RNA Analysis & Transcriptomic Product Introduction

1.2 Global RNA Analysis & Transcriptomic Market Size Forecast (2021–2032)

1.3 RNA Analysis & Transcriptomic Market Trends & Drivers

1.3.1 RNA Analysis & Transcriptomic Industry Trends

1.3.2 RNA Analysis & Transcriptomic Market Drivers & Opportunities

1.3.3 RNA Analysis & Transcriptomic Market Challenges

1.3.4 RNA Analysis & Transcriptomic Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global RNA Analysis & Transcriptomic Players Revenue Ranking (2025)

2.2 Global RNA Analysis & Transcriptomic Revenue by Company (2021–2026)

2.3 Key Companies’ R&D and Operations Footprint and Headquarters

2.4 Key Companies RNA Analysis & Transcriptomic Product Offerings

2.5 Key Companies General Availability (GA) Timeline for RNA Analysis & Transcriptomic

2.6 RNA Analysis & Transcriptomic Market Competitive Analysis

2.6.1 RNA Analysis & Transcriptomic Market Concentration Rate (2021–2026)

2.6.2 Top 5 and Top 10 Global Companies by RNA Analysis & Transcriptomic Revenue in 2025

2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on RNA Analysis & Transcriptomic revenue, 2025

2.7 Mergers & Acquisitions and Expansion

3 Segmentation RNA Analysis & Transcriptomic Market Classification

3.1 Introduction by Type

3.1.1 Microarrays

3.1.2 Sequencing

3.1.3 Polymerase Chain Reaction

3.1.4 RNA Interference

3.1.5 Global RNA Analysis & Transcriptomic Sales Value by Type

3.1.5.1 Global RNA Analysis & Transcriptomic Sales Value by Type (2021 vs 2025 vs 2032)

3.1.5.2 Global RNA Analysis & Transcriptomic Sales Value, by Type (2021–2032)

3.1.5.3 Global RNA Analysis & Transcriptomic Sales Value, by Type (%), 2021–2032

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Clinical Diagnostics

4.1.2 Drug Discovery

4.1.3 Toxicogenomics

4.1.4 Comparative Transcriptomics

4.2 Global RNA Analysis & Transcriptomic Sales Value by Application

4.2.1 Global RNA Analysis & Transcriptomic Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global RNA Analysis & Transcriptomic Sales Value by Application (2021–2032)

4.2.3 Global RNA Analysis & Transcriptomic Sales Value by Application (%), 2021–2032

5 Segmentation by Region

5.1 Global RNA Analysis & Transcriptomic Sales Value by Region

5.1.1 Global RNA Analysis & Transcriptomic Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global RNA Analysis & Transcriptomic Sales Value by Region (2021–2026)

5.1.3 Global RNA Analysis & Transcriptomic Sales Value by Region (2027–2032)

5.1.4 Global RNA Analysis & Transcriptomic Sales Value by Region (%), 2021–2032

5.2 North America

5.2.1 North America RNA Analysis & Transcriptomic Sales Value, 2021–2032

5.2.2 North America RNA Analysis & Transcriptomic Sales Value by Country (%), 2025 vs 2032

5.3 Europe

5.3.1 Europe RNA Analysis & Transcriptomic Sales Value, 2021–2032

5.3.2 Europe RNA Analysis & Transcriptomic Sales Value by Country (%), 2025 vs 2032

5.4 Asia Pacific

5.4.1 Asia Pacific RNA Analysis & Transcriptomic Sales Value, 2021–2032

5.4.2 Asia Pacific RNA Analysis & Transcriptomic Sales Value by Subregion (%), 2025 vs 2032

5.5 South America

5.5.1 South America RNA Analysis & Transcriptomic Sales Value, 2021–2032

5.5.2 South America RNA Analysis & Transcriptomic Sales Value by Country (%), 2025 vs 2032

5.6 Middle East & Africa

5.6.1 Middle East & Africa RNA Analysis & Transcriptomic Sales Value, 2021–2032

5.6.2 Middle East & Africa RNA Analysis & Transcriptomic Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions RNA Analysis & Transcriptomic Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions RNA Analysis & Transcriptomic Sales Value, 2021–2032

6.3 United States

6.3.1 United States RNA Analysis & Transcriptomic Sales Value, 2021–2032

6.3.2 United States RNA Analysis & Transcriptomic Sales Value by Type (%), 2025 vs 2032

6.3.3 United States RNA Analysis & Transcriptomic Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe RNA Analysis & Transcriptomic Sales Value, 2021–2032

6.4.2 Europe RNA Analysis & Transcriptomic Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe RNA Analysis & Transcriptomic Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China RNA Analysis & Transcriptomic Sales Value, 2021–2032

6.5.2 China RNA Analysis & Transcriptomic Sales Value by Type (%), 2025 vs 2032

6.5.3 China RNA Analysis & Transcriptomic Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan RNA Analysis & Transcriptomic Sales Value, 2021–2032

6.6.2 Japan RNA Analysis & Transcriptomic Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan RNA Analysis & Transcriptomic Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea RNA Analysis & Transcriptomic Sales Value, 2021–2032

6.7.2 South Korea RNA Analysis & Transcriptomic Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea RNA Analysis & Transcriptomic Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia RNA Analysis & Transcriptomic Sales Value, 2021–2032

6.8.2 Southeast Asia RNA Analysis & Transcriptomic Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia RNA Analysis & Transcriptomic Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India RNA Analysis & Transcriptomic Sales Value, 2021–2032

6.9.2 India RNA Analysis & Transcriptomic Sales Value by Type (%), 2025 vs 2032

6.9.3 India RNA Analysis & Transcriptomic Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 Thermo Fisher Scientific, Inc.

7.1.1 Thermo Fisher Scientific, Inc. Profile

7.1.2 Thermo Fisher Scientific, Inc. Main Business

7.1.3 Thermo Fisher Scientific, Inc. RNA Analysis & Transcriptomic Products, Services, and Solutions

7.1.4 Thermo Fisher Scientific, Inc. RNA Analysis & Transcriptomic Revenue (US$ Million), 2021–2026

7.1.5 Thermo Fisher Scientific, Inc. Recent Developments

7.2 Bio-Rad Laboratories, Inc.

7.2.1 Bio-Rad Laboratories, Inc. Profile

7.2.2 Bio-Rad Laboratories, Inc. Main Business

7.2.3 Bio-Rad Laboratories, Inc. RNA Analysis & Transcriptomic Products, Services, and Solutions

7.2.4 Bio-Rad Laboratories, Inc. RNA Analysis & Transcriptomic Revenue (US$ Million), 2021–2026

7.2.5 Bio-Rad Laboratories, Inc. Recent Developments

7.3 Merck KGaA

7.3.1 Merck KGaA Profile

7.3.2 Merck KGaA Main Business

7.3.3 Merck KGaA RNA Analysis & Transcriptomic Products, Services, and Solutions

7.3.4 Merck KGaA RNA Analysis & Transcriptomic Revenue (US$ Million), 2021–2026

7.3.5 Merck KGaA Recent Developments

7.4 Agilent Technologies, Inc.

7.4.1 Agilent Technologies, Inc. Profile

7.4.2 Agilent Technologies, Inc. Main Business

7.4.3 Agilent Technologies, Inc. RNA Analysis & Transcriptomic Products, Services, and Solutions

7.4.4 Agilent Technologies, Inc. RNA Analysis & Transcriptomic Revenue (US$ Million), 2021–2026

7.4.5 Agilent Technologies, Inc. Recent Developments

7.5 F. Hoffmann-La Roche Ltd.

7.5.1 F. Hoffmann-La Roche Ltd. Profile

7.5.2 F. Hoffmann-La Roche Ltd. Main Business

7.5.3 F. Hoffmann-La Roche Ltd. RNA Analysis & Transcriptomic Products, Services, and Solutions

7.5.4 F. Hoffmann-La Roche Ltd. RNA Analysis & Transcriptomic Revenue (US$ Million), 2021–2026

7.5.5 F. Hoffmann-La Roche Ltd. Recent Developments

7.6 Danaher Corporation

7.6.1 Danaher Corporation Profile

7.6.2 Danaher Corporation Main Business

7.6.3 Danaher Corporation RNA Analysis & Transcriptomic Products, Services, and Solutions

7.6.4 Danaher Corporation RNA Analysis & Transcriptomic Revenue (US$ Million), 2021–2026

7.6.5 Danaher Corporation Recent Developments

7.7 Fluidigm Corporation

7.7.1 Fluidigm Corporation Profile

7.7.2 Fluidigm Corporation Main Business

7.7.3 Fluidigm Corporation RNA Analysis & Transcriptomic Products, Services, and Solutions

7.7.4 Fluidigm Corporation RNA Analysis & Transcriptomic Revenue (US$ Million), 2021–2026

7.7.5 Fluidigm Corporation Recent Developments

7.8 Eurofins Scientific

7.8.1 Eurofins Scientific Profile

7.8.2 Eurofins Scientific Main Business

7.8.3 Eurofins Scientific RNA Analysis & Transcriptomic Products, Services, and Solutions

7.8.4 Eurofins Scientific RNA Analysis & Transcriptomic Revenue (US$ Million), 2021–2026

7.8.5 Eurofins Scientific Recent Developments

7.9 Sequentia Biotech SL

7.9.1 Sequentia Biotech SL Profile

7.9.2 Sequentia Biotech SL Main Business

7.9.3 Sequentia Biotech SL RNA Analysis & Transcriptomic Products, Services, and Solutions

7.9.4 Sequentia Biotech SL RNA Analysis & Transcriptomic Revenue (US$ Million), 2021–2026

7.9.5 Sequentia Biotech SL Recent Developments

7.10 Acobiom

7.10.1 Acobiom Profile

7.10.2 Acobiom Main Business

7.10.3 Acobiom RNA Analysis & Transcriptomic Products, Services, and Solutions

7.10.4 Acobiom RNA Analysis & Transcriptomic Revenue (US$ Million), 2021–2026

7.10.5 Acobiom Recent Developments

7.11 GenXPro GmbH

7.11.1 GenXPro GmbH Profile

7.11.2 GenXPro GmbH Main Business

7.11.3 GenXPro GmbH RNA Analysis & Transcriptomic Products, Services, and Solutions

7.11.4 GenXPro GmbH RNA Analysis & Transcriptomic Revenue (US$ Million), 2021–2026

7.11.5 GenXPro GmbH Recent Developments

7.12 CD Genomics

7.12.1 CD Genomics Profile

7.12.2 CD Genomics Main Business

7.12.3 CD Genomics RNA Analysis & Transcriptomic Products, Services, and Solutions

7.12.4 CD Genomics RNA Analysis & Transcriptomic Revenue (US$ Million), 2021–2026

7.12.5 CD Genomics Recent Developments

7.13 Promega Corporation

7.13.1 Promega Corporation Profile

7.13.2 Promega Corporation Main Business

7.13.3 Promega Corporation RNA Analysis & Transcriptomic Products, Services, and Solutions

7.13.4 Promega Corporation RNA Analysis & Transcriptomic Revenue (US$ Million), 2021–2026

7.13.5 Promega Corporation Recent Developments

7.14 Cenix BioScience GmbH

7.14.1 Cenix BioScience GmbH Profile

7.14.2 Cenix BioScience GmbH Main Business

7.14.3 Cenix BioScience GmbH RNA Analysis & Transcriptomic Products, Services, and Solutions

7.14.4 Cenix BioScience GmbH RNA Analysis & Transcriptomic Revenue (US$ Million), 2021–2026

7.14.5 Cenix BioScience GmbH Recent Developments

7.15 Takara Holdings, Inc.

7.15.1 Takara Holdings, Inc. Profile

7.15.2 Takara Holdings, Inc. Main Business

7.15.3 Takara Holdings, Inc. RNA Analysis & Transcriptomic Products, Services, and Solutions

7.15.4 Takara Holdings, Inc. RNA Analysis & Transcriptomic Revenue (US$ Million), 2021–2026

7.15.5 Takara Holdings, Inc. Recent Developments

7.16 bioMérieux SA

7.16.1 bioMérieux SA Profile

7.16.2 bioMérieux SA Main Business

7.16.3 bioMérieux SA RNA Analysis & Transcriptomic Products, Services, and Solutions

7.16.4 bioMérieux SA RNA Analysis & Transcriptomic Revenue (US$ Million), 2021–2026

7.16.5 bioMérieux SA Recent Developments

7.17 LC Sciences LLC

7.17.1 LC Sciences LLC Profile

7.17.2 LC Sciences LLC Main Business

7.17.3 LC Sciences LLC RNA Analysis & Transcriptomic Products, Services, and Solutions

7.17.4 LC Sciences LLC RNA Analysis & Transcriptomic Revenue (US$ Million), 2021–2026

7.17.5 LC Sciences LLC Recent Developments

8 Industry Chain Analysis

8.1 RNA Analysis & Transcriptomic Value Chain

8.2 RNA Analysis & Transcriptomic Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Cost Structure

8.3 Midstream Analysis

8.4 Downstream (Customer) Analysis

8.5 Sales Model and Sales Channelss

8.5.1 RNA Analysis & Transcriptomic Sales Model

8.5.2 Sales Channels

8.5.3 RNA Analysis & Transcriptomic Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. RNA Analysis & Transcriptomic Market Trends

Table 2. RNA Analysis & Transcriptomic Market Drivers & Opportunities

Table 3. RNA Analysis & Transcriptomic Market Challenges

Table 4. RNA Analysis & Transcriptomic Market Restraints

Table 5. Global RNA Analysis & Transcriptomic Revenue by Company (US$ Million), 2021–2026

Table 6. Global RNA Analysis & Transcriptomic Revenue Market Share by Company (2021–2026)

Table 7. Key Companies’ R&D and Operations Footprint and Headquarters

Table 8. Key Companies RNA Analysis & Transcriptomic Product Type

Table 9. Key Companies General Availability (GA) Timeline for RNA Analysis & Transcriptomic

Table 10. Global RNA Analysis & Transcriptomic Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on RNA Analysis & Transcriptomic revenue, 2025

Table 12. Mergers & Acquisitions and Expansion Plans

Table 13. Global RNA Analysis & Transcriptomic Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 14. Global RNA Analysis & Transcriptomic Sales Value by Type (US$ Million), 2021–2026

Table 15. Global RNA Analysis & Transcriptomic Sales Value by Type (US$ Million), 2027–2032

Table 16. Global RNA Analysis & Transcriptomic Sales Market Share in Value by Type (2021–2026)

Table 17. Global RNA Analysis & Transcriptomic Sales Market Share in Value by Type (2027–2032)

Table 18. Global RNA Analysis & Transcriptomic Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 19. Global RNA Analysis & Transcriptomic Sales Value by Application (US$ Million), 2021–2026

Table 20. Global RNA Analysis & Transcriptomic Sales Value by Application (US$ Million), 2027–2032

Table 21. Global RNA Analysis & Transcriptomic Sales Market Share in Value by Application (2021–2026)

Table 22. Global RNA Analysis & Transcriptomic Sales Market Share in Value by Application (2027–2032)

Table 23. Global RNA Analysis & Transcriptomic Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 24. Global RNA Analysis & Transcriptomic Sales Value by Region (US$ Million), 2021–2026

Table 25. Global RNA Analysis & Transcriptomic Sales Value by Region (US$ Million), 2027–2032

Table 26. Global RNA Analysis & Transcriptomic Sales Value by Region (%), 2021–2026

Table 27. Global RNA Analysis & Transcriptomic Sales Value by Region (%), 2027–2032

Table 28. Key Countries/Regions RNA Analysis & Transcriptomic Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 29. Key Countries/Regions RNA Analysis & Transcriptomic Sales Value, (US$ Million), 2021–2026

Table 30. Key Countries/Regions RNA Analysis & Transcriptomic Sales Value, (US$ Million), 2027–2032

Table 31. Thermo Fisher Scientific, Inc. Basic Information List

Table 32. Thermo Fisher Scientific, Inc. Description and Business Overview

Table 33. Thermo Fisher Scientific, Inc. RNA Analysis & Transcriptomic Products, Services, and Solutions

Table 34. Revenue (US$ Million) in RNA Analysis & Transcriptomic Business of Thermo Fisher Scientific, Inc. (2021–2026)

Table 35. Thermo Fisher Scientific, Inc. Recent Developments

Table 36. Bio-Rad Laboratories, Inc. Basic Information List

Table 37. Bio-Rad Laboratories, Inc. Description and Business Overview

Table 38. Bio-Rad Laboratories, Inc. RNA Analysis & Transcriptomic Products, Services, and Solutions

Table 39. Revenue (US$ Million) in RNA Analysis & Transcriptomic Business of Bio-Rad Laboratories, Inc. (2021–2026)

Table 40. Bio-Rad Laboratories, Inc. Recent Developments

Table 41. Merck KGaA Basic Information List

Table 42. Merck KGaA Description and Business Overview

Table 43. Merck KGaA RNA Analysis & Transcriptomic Products, Services, and Solutions

Table 44. Revenue (US$ Million) in RNA Analysis & Transcriptomic Business of Merck KGaA (2021–2026)

Table 45. Merck KGaA Recent Developments

Table 46. Agilent Technologies, Inc. Basic Information List

Table 47. Agilent Technologies, Inc. Description and Business Overview

Table 48. Agilent Technologies, Inc. RNA Analysis & Transcriptomic Products, Services, and Solutions

Table 49. Revenue (US$ Million) in RNA Analysis & Transcriptomic Business of Agilent Technologies, Inc. (2021–2026)

Table 50. Agilent Technologies, Inc. Recent Developments

Table 51. F. Hoffmann-La Roche Ltd. Basic Information List

Table 52. F. Hoffmann-La Roche Ltd. Description and Business Overview

Table 53. F. Hoffmann-La Roche Ltd. RNA Analysis & Transcriptomic Products, Services, and Solutions

Table 54. Revenue (US$ Million) in RNA Analysis & Transcriptomic Business of F. Hoffmann-La Roche Ltd. (2021–2026)

Table 55. F. Hoffmann-La Roche Ltd. Recent Developments

Table 56. Danaher Corporation Basic Information List

Table 57. Danaher Corporation Description and Business Overview

Table 58. Danaher Corporation RNA Analysis & Transcriptomic Products, Services, and Solutions

Table 59. Revenue (US$ Million) in RNA Analysis & Transcriptomic Business of Danaher Corporation (2021–2026)

Table 60. Danaher Corporation Recent Developments

Table 61. Fluidigm Corporation Basic Information List

Table 62. Fluidigm Corporation Description and Business Overview

Table 63. Fluidigm Corporation RNA Analysis & Transcriptomic Products, Services, and Solutions

Table 64. Revenue (US$ Million) in RNA Analysis & Transcriptomic Business of Fluidigm Corporation (2021–2026)

Table 65. Fluidigm Corporation Recent Developments

Table 66. Eurofins Scientific Basic Information List

Table 67. Eurofins Scientific Description and Business Overview

Table 68. Eurofins Scientific RNA Analysis & Transcriptomic Products, Services, and Solutions

Table 69. Revenue (US$ Million) in RNA Analysis & Transcriptomic Business of Eurofins Scientific (2021–2026)

Table 70. Eurofins Scientific Recent Developments

Table 71. Sequentia Biotech SL Basic Information List

Table 72. Sequentia Biotech SL Description and Business Overview

Table 73. Sequentia Biotech SL RNA Analysis & Transcriptomic Products, Services, and Solutions

Table 74. Revenue (US$ Million) in RNA Analysis & Transcriptomic Business of Sequentia Biotech SL (2021–2026)

Table 75. Sequentia Biotech SL Recent Developments

Table 76. Acobiom Basic Information List

Table 77. Acobiom Description and Business Overview

Table 78. Acobiom RNA Analysis & Transcriptomic Products, Services, and Solutions

Table 79. Revenue (US$ Million) in RNA Analysis & Transcriptomic Business of Acobiom (2021–2026)

Table 80. Acobiom Recent Developments

Table 81. GenXPro GmbH Basic Information List

Table 82. GenXPro GmbH Description and Business Overview

Table 83. GenXPro GmbH RNA Analysis & Transcriptomic Products, Services, and Solutions

Table 84. Revenue (US$ Million) in RNA Analysis & Transcriptomic Business of GenXPro GmbH (2021–2026)

Table 85. GenXPro GmbH Recent Developments

Table 86. CD Genomics Basic Information List

Table 87. CD Genomics Description and Business Overview

Table 88. CD Genomics RNA Analysis & Transcriptomic Products, Services, and Solutions

Table 89. Revenue (US$ Million) in RNA Analysis & Transcriptomic Business of CD Genomics (2021–2026)

Table 90. CD Genomics Recent Developments

Table 91. Promega Corporation Basic Information List

Table 92. Promega Corporation Description and Business Overview

Table 93. Promega Corporation RNA Analysis & Transcriptomic Products, Services, and Solutions

Table 94. Revenue (US$ Million) in RNA Analysis & Transcriptomic Business of Promega Corporation (2021–2026)

Table 95. Promega Corporation Recent Developments

Table 96. Cenix BioScience GmbH Basic Information List

Table 97. Cenix BioScience GmbH Description and Business Overview

Table 98. Cenix BioScience GmbH RNA Analysis & Transcriptomic Products, Services, and Solutions

Table 99. Revenue (US$ Million) in RNA Analysis & Transcriptomic Business of Cenix BioScience GmbH (2021–2026)

Table 100. Cenix BioScience GmbH Recent Developments

Table 101. Takara Holdings, Inc. Basic Information List

Table 102. Takara Holdings, Inc. Description and Business Overview

Table 103. Takara Holdings, Inc. RNA Analysis & Transcriptomic Products, Services, and Solutions

Table 104. Revenue (US$ Million) in RNA Analysis & Transcriptomic Business of Takara Holdings, Inc. (2021–2026)

Table 105. Takara Holdings, Inc. Recent Developments

Table 106. bioMérieux SA Basic Information List

Table 107. bioMérieux SA Description and Business Overview

Table 108. bioMérieux SA RNA Analysis & Transcriptomic Products, Services, and Solutions

Table 109. Revenue (US$ Million) in RNA Analysis & Transcriptomic Business of bioMérieux SA (2021–2026)

Table 110. bioMérieux SA Recent Developments

Table 111. LC Sciences LLC Basic Information List

Table 112. LC Sciences LLC Description and Business Overview

Table 113. LC Sciences LLC RNA Analysis & Transcriptomic Products, Services, and Solutions

Table 114. Revenue (US$ Million) in RNA Analysis & Transcriptomic Business of LC Sciences LLC (2021–2026)

Table 115. LC Sciences LLC Recent Developments

Table 116. Revenue (US$ Million) in RNA Analysis & Transcriptomic Business of Company 40 (2021–2026)

Table 117. Company 40 Recent Developments

Table 118. Key Raw Materials Lists

Table 119. Key Suppliers of Raw Materials Lists

Table 120. RNA Analysis & Transcriptomic Downstream Customers

Table 121. RNA Analysis & Transcriptomic Distributors List

Table 122. Research Programs/Design for This Report

Table 123. Key Data Information from Secondary Sources

Table 124. Key Data Information from Primary Sources

List of Figures

Figure 1. RNA Analysis & Transcriptomic Product Picture

Figure 2. Global RNA Analysis & Transcriptomic Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global RNA Analysis & Transcriptomic Sales Value (US$ Million), 2021–2032

Figure 4. RNA Analysis & Transcriptomic Report Years Considered

Figure 5. Global RNA Analysis & Transcriptomic Players Revenue Ranking (US$ Million), 2025

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by RNA Analysis & Transcriptomic Revenue in 2025

Figure 7. RNA Analysis & Transcriptomic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 8. Microarrays Picture

Figure 9. Sequencing Picture

Figure 10. Polymerase Chain Reaction Picture

Figure 11. RNA Interference Picture

Figure 12. Global RNA Analysis & Transcriptomic Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 13. Global RNA Analysis & Transcriptomic Sales Value Market Share by Type, 2025 & 2032

Figure 14. Product Picture of Clinical Diagnostics

Figure 15. Product Picture of Drug Discovery

Figure 16. Product Picture of Toxicogenomics

Figure 17. Product Picture of Comparative Transcriptomics

Figure 18. Global RNA Analysis & Transcriptomic Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 19. Global RNA Analysis & Transcriptomic Sales Value Market Share by Application, 2025 & 2032

Figure 20. North America RNA Analysis & Transcriptomic Sales Value (US$ Million), 2021–2032

Figure 21. North America RNA Analysis & Transcriptomic Sales Value by Country (%), 2025 vs 2032

Figure 22. Europe RNA Analysis & Transcriptomic Sales Value (US$ Million), 2021–2032

Figure 23. Europe RNA Analysis & Transcriptomic Sales Value by Country (%), 2025 vs 2032

Figure 24. Asia Pacific RNA Analysis & Transcriptomic Sales Value (US$ Million), 2021–2032

Figure 25. Asia Pacific RNA Analysis & Transcriptomic Sales Value by Subregion (%), 2025 vs 2032

Figure 26. South America RNA Analysis & Transcriptomic Sales Value (US$ Million), 2021–2032

Figure 27. South America RNA Analysis & Transcriptomic Sales Value by Country (%), 2025 vs 2032

Figure 28. Middle East & Africa RNA Analysis & Transcriptomic Sales Value (US$ Million), 2021–2032

Figure 29. Middle East & Africa RNA Analysis & Transcriptomic Sales Value by Country (%), 2025 vs 2032

Figure 30. Key Countries/Regions RNA Analysis & Transcriptomic Sales Value (%), 2021–2032

Figure 31. United States RNA Analysis & Transcriptomic Sales Value (US$ Million), 2021–2032

Figure 32. United States RNA Analysis & Transcriptomic Sales Value by Type (%), 2025 vs 2032

Figure 33. United States RNA Analysis & Transcriptomic Sales Value by Application (%), 2025 vs 2032

Figure 34. Europe RNA Analysis & Transcriptomic Sales Value (US$ Million), 2021–2032

Figure 35. Europe RNA Analysis & Transcriptomic Sales Value by Type (%), 2025 vs 2032

Figure 36. Europe RNA Analysis & Transcriptomic Sales Value by Application (%), 2025 vs 2032

Figure 37. China RNA Analysis & Transcriptomic Sales Value (US$ Million), 2021–2032

Figure 38. China RNA Analysis & Transcriptomic Sales Value by Type (%), 2025 vs 2032

Figure 39. China RNA Analysis & Transcriptomic Sales Value by Application (%), 2025 vs 2032

Figure 40. Japan RNA Analysis & Transcriptomic Sales Value (US$ Million), 2021–2032

Figure 41. Japan RNA Analysis & Transcriptomic Sales Value by Type (%), 2025 vs 2032

Figure 42. Japan RNA Analysis & Transcriptomic Sales Value by Application (%), 2025 vs 2032

Figure 43. South Korea RNA Analysis & Transcriptomic Sales Value (US$ Million), 2021–2032

Figure 44. South Korea RNA Analysis & Transcriptomic Sales Value by Type (%), 2025 vs 2032

Figure 45. South Korea RNA Analysis & Transcriptomic Sales Value by Application (%), 2025 vs 2032

Figure 46. Southeast Asia RNA Analysis & Transcriptomic Sales Value (US$ Million), 2021–2032

Figure 47. Southeast Asia RNA Analysis & Transcriptomic Sales Value by Type (%), 2025 vs 2032

Figure 48. Southeast Asia RNA Analysis & Transcriptomic Sales Value by Application (%), 2025 vs 2032

Figure 49. India RNA Analysis & Transcriptomic Sales Value (US$ Million), 2021–2032

Figure 50. India RNA Analysis & Transcriptomic Sales Value by Type (%), 2025 vs 2032

Figure 51. India RNA Analysis & Transcriptomic Sales Value by Application (%), 2025 vs 2032

Figure 52. RNA Analysis & Transcriptomic Value Chain

Figure 53. RNA Analysis & Transcriptomic Cost Structure

Figure 54. Channels of Distribution (Direct Sales, and Distribution)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global RNA Analysis & Transcriptomic market? zhanKai

The top companies in the global RNA Analysis & Transcriptomic market are Thermo Fisher Scientific, Inc.、Bio-Rad Laboratories, Inc.、Merck KGaA.

Related Reports

Global RNA Analysis & Transcriptomic Market Research Report 2026
The global RNA Analysis & Transcriptomic market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 128
USD 2900.00
(Single User License)
Global RNA Analysis & Transcriptomic Market Outlook, In‑Depth Analysis & Forecast to 2031
The global RNA Analysis & Transcriptomic market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 155
USD 4900.00
(Single User License)
Global RNA Analysis & Transcriptomic Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global RNA Analysis & Transcriptomic market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-19
Pages: 101
USD 4250.00
(Single User License)
RNA Analysis & Transcriptomic- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for RNA Analysis & Transcriptomic was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-19
Pages: 126
USD 3950.00
(Single User License)
Global RNA Analysis & Transcriptomic Market Research Report 2025
The global market for RNA Analysis & Transcriptomic was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-19
Pages: 95
USD 2900.00
(Single User License)
Global RNA Analysis & Transcriptomic Market Insights, Forecast to 2030
Market Analysis and Insights: Global RNA Analysis & Transcriptomic Market
Published Date: 2024-04-07
Pages: 112
USD 4900.00
(Single User License)
RNA Analysis & Transcriptomic - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for RNA Analysis & Transcriptomic was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-19
Pages: 126
USD 3950.00
(Single User License)
Global RNA Analysis & Transcriptomic Market Research Report 2024
The global RNA Analysis & Transcriptomic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-16
Pages: 92
USD 2900.00
(Single User License)

Global RNA Analysis & Transcriptomic Market Research Report 2026
The global RNA Analysis & Transcriptomic market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 128
USD 2900.00 (Single User License)
Global RNA Analysis & Transcriptomic Market Outlook, In‑Depth Analysis & Forecast to 2031
The global RNA Analysis & Transcriptomic market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 155
USD 4900.00 (Single User License)
Global RNA Analysis & Transcriptomic Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global RNA Analysis & Transcriptomic market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-19
Pages: 101
USD 4250.00 (Single User License)
RNA Analysis & Transcriptomic- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for RNA Analysis & Transcriptomic was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-19
Pages: 126
USD 3950.00 (Single User License)
Global RNA Analysis & Transcriptomic Market Research Report 2025
The global market for RNA Analysis & Transcriptomic was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-19
Pages: 95
USD 2900.00 (Single User License)
Global RNA Analysis & Transcriptomic Market Insights, Forecast to 2030
Market Analysis and Insights: Global RNA Analysis & Transcriptomic Market
Published: 2024-04-07
Pages: 112
USD 4900.00 (Single User License)
RNA Analysis & Transcriptomic - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for RNA Analysis & Transcriptomic was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-19
Pages: 126
USD 3950.00 (Single User License)
Global RNA Analysis & Transcriptomic Market Research Report 2024
The global RNA Analysis & Transcriptomic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-16
Pages: 92
USD 2900.00 (Single User License)